Brain

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL...

Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC

Illustrative image Laboratory, Boehringer Ingelheim This press release is not intended for UK and US media.  HERNEXEOS® (zongertinib tablets) has been...

FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners...

Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases

Ease Expands Its Online Veterinary Behavior Solution, Offering Pet Parents Expert Treatment for Pet Stress, Anxiety and Behavior Problems in the Comfort of Home

With veterinary clinic partners across 34 states, Ease is building the first centralized platform for veterinary behavioral medicine while keeping...

error: Content is protected !!